http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#Head
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#assertion
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#provenance
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#pubinfo
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#assertion
http://purl.obolibrary.org/obo/DOID_1558
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_1558
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00722
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association
http://www.w3.org/2000/01/rdf-schema#label
"PRINIVIL is contraindicated in patients with: a history of angioedema or hypersensitivity related to previous treatment with an angiotensin converting enzyme inhibitor hereditary or idiopathic angioedema. Do not coadminister aliskiren with PRINIVIL in patients with diabetes [see Drug Interactions (7.4) PRINIVIL is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer PRINIVIL within 36 hours of switching to or from sacubitril/valsartan, a product containing a neprilysin inhibitor [see Warnings and Precautions (5.2) Drug Interactions (7.8) Angioedema or a history of hereditary or idiopathic angioedema ( 4 Hypersensitivity ( 4 Coadministration of aliskiren with PRINIVIL in patients with diabetes ( 4 7.4 PRINIVIL is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer PRINIVIL within 36 hours of switching to or from sacubitril/valsartan, a product containing a neprilysin inhibitor ( 4"
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB00722
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#provenance
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#pubinfo
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#sig
http://purl.org/nanopub/x/hasSignature
TGKotDMizhLpKLj1hlHyxQ8SVIw8wUoeTur0vtFLNSzbYvfk4aAZd6ydLbBDdO1sHcomTJFZP6sOt6AwZa6ticlDtFyVOHm5dI5T3J7cRKAhseshr9SbfsAnuRwAqwrbYfY0Y89YIOaqD029hYsjlJ1XTguhBzKR4vZF002DojQ=
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk
http://purl.org/dc/terms/created
2021-08-23T12:15:44.690+02:00
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAu_OKDKznq7yYDh8llqf_HaqnSJourrbv4kRtL_HUfVk
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY